Darolutamide plus ADT approved in EU for mHSPC
Mitomycin intravesical solution demonstrates long-term durability in LG-IR-NMIBC
Experts urge FDA to remove black box warning on low-dose vaginal estrogen
Phase 3 TALAPRO-2 data of talazoparib plus enzalutamide published in The Lancet